news
BNIP1 identified as a risk gene for ALS
Broad data analysis points to genetic similarities between Lou Gehrig's Disease and a form of dementia...
List view / Grid view
Amyotrophic Lateral Sclerosis (ALS)
news
KIF5A gene associated with the development of ALS
An international team of researchers has identified a new gene associated with the development of amyotrophic lateral sclerosis...
news
CRISPR helps find new genetic suspects behind ALS/FTD
Study provides a roadmap for using CRISPR to investigate neurological disorders...
news
Change in neuron size could shed light on new treatments for ALS
Understanding how motor nerve cells respond to motor neurone disease could help researchers identify new treatment options...
news
Anle138b blocks toxic ion flow linked to Alzheimer’s disease
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer's disease by stopping toxic ion flow in the brain...
news
Protein associated with ALS points to possible targets for therapeutic intervention
Scientists may have found possible targets for therapeutic interventions in the fight against Lou Gehrig’s disease.
news
Phenogenetic map created for stem cell models of neurological diseases
Researchers have performed meta-analysis of neurological and neurodegenerative diseases and created an atlas of how cell characteristics are linked to their genotype...
news
NIH awards $15m to support development of 3-D human tissue models
The NIH has announced 13 two-year awards totalling $15m, to develop 3-D microphysiological system platforms that model human disease...
news
New gene variant identified in ALS provides treatment hope
A new study shows that a variant in UBQLN4 gene has been associated with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS). The study also describes how this gene variant disrupts a cellular process that drives motor neuron development. This new insight opens the door to potential treatment targets for…
article
Turning rare diseases into efficient targets with AI
BenevolentBio's CMO, Dr Patrick Keohane, says the industry is on the cusp of an artificial intelligence (AI) revolution...
news
JPND launches €23 million call for neurodegenerative disease research
Neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease are a global health, economic and social emergency.
news
ALS study reveals role of RNA-binding proteins and provides new therapeutic target
20 October 2016 | By Niamh Louise Marriott, Digital Content Producer
To unravel the role RNA-binding proteins play in ALS, Yeo's team gathered skin cells from ALS patients, three with a mutation in the hnRNP A2/B1 gene...
news
New protein target could treat genetic cause of ALS
15 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Targeting a single protein, SUPT4H1, reduces the levels of the three toxic entities created by the C9orf72 gene expansion, the most common genetic cause of ALS...
news
Researchers develop unique model for studying ALS
22 April 2016 | By Victoria White, Digital Content Producer
Researchers have developed a unique mouse model that will allow scientists to better study the genetic origins and potential treatments for ALS...
news
New therapy halts progression of ALS in mice
29 January 2016 | By Victoria White
Researchers have announced that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS) for nearly two years in one type of mouse model...
